Bortezomib Injection IP Winzomib 3.5

Name: Bortezomib Injection IP Winzomib 3.5
Brand: PHP Lifesciences LLP
Price: 1140 INR
Availability: InStock

Price 1140 INR/ Vial

Get a Price/Quote

MOQ : 10 Vials

Bortezomib Injection IP Winzomib 3.5 Specification

Indication
Multiple Myeloma, Mantle Cell Lymphoma

Dosage Form
Lyophilized Powder for Injection

Salt Composition
Bortezomib 3.5 mg

Feature
Stable lyophilized formulation, easy reconstitution

Application

Ph Level
Approximately 4-7 (when reconstituted)

Physical Color/Texture
White to off-white Lyophilized Powder

Fermentation Smell
Odorless

Storage Instructions
Store below 25C in the original package, protect from light

Shelf Life
24 Months

Packaging Type
Single-use glass vial

Reconstituted Solution Use
Use within 8 hours of reconstitution if stored at 25C

Reconstitution Solvent
0.9% Sodium Chloride Injection

Pack Size
1 Vial per Box

Preservative
No preservative

Prescription Required
Yes

Regulatory Status
Prescription Only Medicine (Rx)

Administration Route
Intravenous or Subcutaneous

Bortezomib Injection IP Winzomib 3.5 Trade Information

Minimum Order Quantity
10 Vials

Supply Ability
1000 Vials Per Month

Delivery Time
7 Days

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Main Domestic Market
All India

About Bortezomib Injection IP Winzomib 3.5

Buy Bortezomib Injection IP Winzomib 3.5 today and take advantage of an enlightened approach to cancer therapy. This masterpiece in oncology is designed for intravenous or subcutaneous administration, offering unbeatable flexibility and efficacy for patients battling multiple myeloma and mantle cell lymphoma. Each single-use glass vial contains 3.5 mg of Bortezomib as a lyophilized powder, ensuring stable formulation and easy reconstitution with 0.9% sodium chloride. Access this prescription-only medicine-crafted for potency, purity, and safety-from dealer, distributor, exporter, or wholesaler in India. Store below 25C, protect from light, and use within eight hours post-reconstitution.

Superior Anticancer Efficacy and Enhanced Usability

Bortezomib Injection IP Winzomib 3.5 is specifically indicated for the treatment of multiple myeloma and mantle cell lymphoma. Its highly stable lyophilized formulation ensures easy and rapid reconstitution, giving healthcare professionals confidence and convenience in high-stakes environments. With precise pH control, a preservative-free profile, and a shelf life of 24 months, Winzomib delivers unmatched safety and efficacy. Choose this outstanding product to benefit from robust clinical results and unparalleled handling features.

Trusted Quality, Certifications, and Reliable Supply

Winzomib 3.5 assures excellence through stringent certifications for quality and safety. Benefit from a sample policy tailored to dealers and distributors seeking assurance of product integrity. Serving the Indian domestic market, we guarantee quick dispatch and stock readiness, ensuring uninterrupted supply. Our commitment to compliance and customer satisfaction establishes Winzomib as the preferred choice for those seeking a reliable, high-quality anticancer solution.

FAQ's of Bortezomib Injection IP Winzomib 3.5:

Q: How should Bortezomib Injection IP Winzomib 3.5 be reconstituted for administration?

A: Reconstitute each vial using 0.9% Sodium Chloride Injection. Mix gently until fully dissolved, and use the solution within eight hours if stored at 25C.

Q: What are the main indications for Winzomib 3.5?

A: Winzomib 3.5 is primarily indicated for the treatment of multiple myeloma and mantle cell lymphoma as part of anticancer chemotherapy.

Q: When should the reconstituted solution be used?

A: The reconstituted solution should be used within eight hours after preparation, provided it is stored at room temperature (25C) and protected from light.

Q: Where can healthcare providers purchase Winzomib 3.5 in India?

A: Healthcare providers can access Winzomib 3.5 through authorized dealers, distributors, exporters, suppliers, and wholesalers across the Indian domestic market.

Q: What are the benefits of Winzomib's lyophilized formulation?

A: Its lyophilized powder form offers stable storage, easy reconstitution, and ensures the product remains effective throughout its shelf life, making it practical and reliable for clinical use.